Mr. Xu Wang has served as our director and chief executive officer since June 2024. He has over twenty years of senior management and extensive operational experience at a number of major pharmaceutical manufacturers, including GSK, Takeda, and others.

Since 2021, he has served as the General Manager of Xiamen Innovax Co., Ltd., where he enhanced HPV vaccine production capacity. Prior to that, Mr. Wang worked at Takeda Pharmaceuticals from 2012 to 2020, where he was responsible for the operation and management of commercial-scale manufacturing facilities in Guangzhou, China and Singen, Germany. From 2001 to 2012, Mr. Wang worked at Shanghai GSK Biologics. Mr. Wang was recognized as a Fujian Province Class A Talent and served as an NMPA GMP Instructor. Mr. Wang graduated from Fudan University and obtained a Master of Science degree.